Disposition of haloperidol pyridinium and reduced haloperidol pyridinium in schizophrenic patients: no relationship with clinical variables during short-term treatment / Sven Ulrich en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 2 (Abril) . - pp. 210-219 Título : Disposition of haloperidol pyridinium and reduced haloperidol pyridinium in schizophrenic patients: no relationship with clinical variables during short-term treatment Tipo de documento: texto impreso Autores: Sven Ulrich, Autor ; Sabine Neuhof, Autor ; Verena Braun, Autor Fecha de publicación: 2023 Artículo en la página: pp. 210-219 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Haloperidol, Compuestos de piridinio, Esquizofrenia. Resumen: In an open clinical trial, serum concentrations of haloperidol pyridinium (CHP+) and reduced haloperidol pyridinium (CRHP+), as well as haloperidol (CH) and reduced haloperidol (CRH), were measured in 57 schizophrenic and schizoaffective inpatients during 6 weeks of short-term treatment. Psychopathology was monitored with the Brief Psychiatric Rating Scale (BPRS), and extrapyramidal adverse effects were assessed with the Extrapyramidal Symptom Rating Scale (EPS). Link: ./index.php?lvl=notice_display&id=31217 [artículo] Disposition of haloperidol pyridinium and reduced haloperidol pyridinium in schizophrenic patients: no relationship with clinical variables during short-term treatment [texto impreso] / Sven Ulrich, Autor ; Sabine Neuhof, Autor ; Verena Braun, Autor . - 2023 . - pp. 210-219. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 2 (Abril) . - pp. 210-219 Palabras clave: Antipsicóticos, Haloperidol, Compuestos de piridinio, Esquizofrenia. Resumen: In an open clinical trial, serum concentrations of haloperidol pyridinium (CHP+) and reduced haloperidol pyridinium (CRHP+), as well as haloperidol (CH) and reduced haloperidol (CRH), were measured in 57 schizophrenic and schizoaffective inpatients during 6 weeks of short-term treatment. Psychopathology was monitored with the Brief Psychiatric Rating Scale (BPRS), and extrapyramidal adverse effects were assessed with the Extrapyramidal Symptom Rating Scale (EPS). Link: ./index.php?lvl=notice_display&id=31217

---

1 (1 - 1 / 1)